Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Gilles Fénelon · Brain · 2000 · 1K citations

Medicine, Neurology, Psychiatry +13

Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease

C. Warren Olanow, Karl Kieburtz, Olivier Rascol et al. · Movement Disorders · 2013 · 468 citations

Medicine, Neurology, Pharmacotherapy +15

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Regina Katzenschlager, Werner Poewe, Olivier Rascol et al. · The Lancet Neurology · 2018 · 318 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and Dyskinesia

Robert A. Hauser, Jeffrey Friedlander, Theresa Zesiewicz et al. · Clinical Neuropharmacology · 2000 · 298 citations

Medicine, Neurology, Functional Movement Assessment +14

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 239 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14